On the other hand, though, pharmacological treatment aiming at activating Nrf2 pathway might counteract the negative effect exerted by mutSOD1 and might represent a promising therapeutic perspective for ALS. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.